Pujade-Lauraine, Eric;
Fujiwara, Keiichi;
Ledermann, Jonathan A;
Oza, Amit M;
Kristeleit, Rebecca;
Ray-Coquard, Isabelle-Laure;
Richardson, Gary E;
... Monk, Bradley J; + view all
(2021)
Avelumab Alone or in Combination With Chemotherapy Versus Chemotherapy Alone in Platinum-Resistant or Platinum-Refractory Ovarian Cancer (JAVELIN Ovarian 200): An Open-Label, Three-Arm, Randomised, Phase 3 Study.
Obstetrical & Gynecological Survey
, 76
(11)
pp. 673-675.
10.1097/OGX.0000000000000980.
Preview |
Text
JAV_Ovarian_200_Ms_Accepted.pdf - Accepted Version Download (8MB) | Preview |
Abstract
The majority of patients with ovarian cancer will experience relapse and develop platinum-resistant disease after being treated with frontline platinum-based chemotherapy. Treatment options for platinum-resistance or platinum-refractory disease are very limited, usually involving nonplatinum chemotherapy, and they are associated with poor objective response rates and life expectancy.
| Type: | Article |
|---|---|
| Title: | Avelumab Alone or in Combination With Chemotherapy Versus Chemotherapy Alone in Platinum-Resistant or Platinum-Refractory Ovarian Cancer (JAVELIN Ovarian 200): An Open-Label, Three-Arm, Randomised, Phase 3 Study |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1097/OGX.0000000000000980 |
| Publisher version: | https://doi.org/10.1097/OGX.0000000000000980 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions. |
| UCL classification: | UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > CRUK Cancer Trials Centre UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10143082 |
Archive Staff Only
 |
View Item |
